Ursula Fritsch serves as Executive at Anthera Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Ursula Fritsch has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2010 involved receiving (via award) 7,500 shares valued at $0.
Ursula Fritsch currently holds 83,615 shares of Anthera Pharmaceuticals Inc (ANTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ursula Fritsch has been a net neutral trader of ANTH stock. They have purchased $0 and sold $0 worth of shares.
Ursula Fritsch's most recent insider trade was on Jun 30, 2010, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 4, 2010 | ANTH | $0 | Conversion | 17,523 | $N/A | Discretionary |